StockData
Biodexa Pharmaceuticals Plc logo

Biodexa Pharmaceuticals Plc (BDRX) stock

BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 1/30
$2.04−0.10 (-4.89%)

Close on Nov 18, 2026Market cap $4.60MP/E –Yield –

Biodexa Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2023 it was £381.00K, down 45.5% from the year before. The highest annual figure on record is £1.94M in fiscal 2018.

Annual revenue

PeriodPeriod endValueChange
FY2023Dec 31, 2023£381.00K-45.5%
FY2022Dec 31, 2022£699.00K+20.9%
FY2021Dec 31, 2021£578.00K+68.5%
FY2020Dec 31, 2020£343.00K-49.1%
FY2019Dec 31, 2019£674.00K-65.2%
FY2018Dec 31, 2018£1.94M+96.0%
FY2017Dec 31, 2017£989.00K-25.2%
FY2016Dec 31, 2016£1.32M-3.8%
FY2015Dec 31, 2015£1.38M–

More Biodexa Pharmaceuticals figures

See a number that looks wrong?